Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091689
Status:
COMPLETED
Last Update Posted:
2008-10-27
First Post:
2004-09-15
Brief Title:
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
Sponsor:
Organization:
Pfizer